The translocation motif of hepatitis B virus improves protein vaccination

Cellular and Molecular Life Sciences

Volumn 63, Issue 5, 2006, Pages 627-635

  Bleifuss, E ^a,e   Kammertoens, T ^b   Hutloff, A ^a   Quarcoo, D ^b   Dorner, M ^a   Straub, P ^b   Uckert, W ^c   Hildt, E ^a,c,d  

^a ROBERT KOCH INSTITUTE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Cell penetrating peptide; Ovalbumin; Protein vaccination; Translocation motif of hepatitis B virus; Tumor immunity

Indexed keywords

ARGINYLGLYCYLTYROSYLVALYLTYROSYLGLUTAMINYLGLYCYLLEUCINE; CPG OLIGODEOXYNUCLEOTIDE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2A; OVALBUMIN; SERYLISOLEUCYLISOLEUCYLASPARAGINYLPHENYLALANYLGLUTAMYLLYSYLLEUCINE; THREONYLLEUCYLSERYLSERYLISOLEUCYLPHENYLALANYLSERYLARGINYLISOLEUCYLGLYCYL ASPARTYLPROLINE; UNCLASSIFIED DRUG;

ADJUVANT CHEMOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL PERMEABILIZATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; EXPRESSION VECTOR; HEPATITIS B VIRUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; THYMOMA; TITRIMETRY; TRANSLOCATION LINE; VACCINATION; VIRUS VECTOR;

AMINO ACID MOTIFS; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS B VIRUS; HUMANS; IMMUNOGLOBULIN G; MICE; OVALBUMIN; RECOMBINANT FUSION PROTEINS; SPLEEN; T-LYMPHOCYTES; VACCINATION; VACCINES, SYNTHETIC;

ANIMALIA; HEPATITIS B VIRUS;

EID: 33645055385     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-005-5548-7     Document Type: Article

References (31)

1. Derossi D., Chassaing G. and Prochiantz A. (1998) Trojan peptides: the penetratin system for intracellular delivery. Trends Cell. Biol. 8: 84-87
2. Vives E., Brodin P. and Lebleu B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272: 16010-16017
3. Rojas M., Donahue J. P., Tan Z. and Lin Y. Z. (1998) Genetic engineering of proteins with cell membrane permeability. Nat. Biotechnol. 16: 370-375
4. Elliott G. and O'Hare P. (1997) Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88: 223-233
5. Thoren P. E., Persson D., Karlsson M. and Norden B. (2000) The antennapedia peptide penetratin translocates across lipid bilayers - the first direct observation. FEBS Lett. 482: 265-268
6. Lundberg P. and Langel U. (2003) A brief introduction to cell-penetrating peptides. J. Mol. Recogn. 16: 227-233
7. Fischer P. M., Krausz E. and Lane D. P. (2001) Cellular delivery of impermeable effector molecules in the form of conjugates with peptides capable of mediating membrane translocation. Bioconjug. Chem. 12: 825-841
8. Lindgren M., Hallbrink M., Prochiantz A. and Langel U. (2000) Cell-penetrating peptides. Trends Pharmacol. Sci. 21: 99-103
9. Drin G., Cottin S., Blanc E., Rees A. R. and Temsamani J. (2003) Studies on the internalization mechanism of cationic cell-penetrating peptides. J. Biol. Chem. 278: 31192-31201
10. Fischer R., Kohler K., Fotin-Mleczek M. and Brock R. (2004) A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides. J. Biol. Chem. 279: 12625-12635
11. Thoren P. E., Persson D., Isakson P., Goksor M., Onfelt A. and Norden B. (2003) Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells. Biochem. Biophys. Res. Commun. 307: 100-107
12. Oess S. and Hildt E. (2000) Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens. Gene Ther. 7: 750-758
13. Hafner A., Brandenburg B. and Hildt E. (2003) Reconstitution of gene expression from a regulatory-protein-deficient hepatitis B virus genome by cell-permeable HBx protein. EMBO Rep. 4: 767-773
14. Stockl L., Berting A., Malkowski B., Foerste R., Hofschneider P. H. and Hildt E. (2003) Integrity of c-Raf-1/MEK signal transduction cascade is essential for hepatitis B virus gene expression. Oncogene 22: 2604-2610
15. Hillemann A., Brandenburg B., Schmidt U., Roos M., Smirnow I., Lemken M. L. et al. (2005) Protein transduction with bacterial cytosine deaminase fused to the TLM intercellular transport motif induces profound chemosensitivity to 5-fluorocytosine in human hepatoma cells. J. Hepatol. 43: 442-450
16. Belz G. T., Carbone F. R. and Heath W. R. (2002) Cross-presentation of antigens by dendritic cells. Crit. Rev. Immunol. 22: 439-448
17. Fong L. and Engleman E. G. (2000) Dendritic cells in cancer immunotherapy. Annu. Rev. Immunol. 18: 245-273
18. Brossart P., Wirths S., Brugger W. and Kanz L. (2001) Dendritic cells in cancer vaccines. Exp. Hematol. 29: 1247-1255
19. Whiteside T. L. and Odoux C. (2004) Dendritic cell biology and cancer therapy. Cancer Immunol. Immunother. 53: 240-248
20. Schutze-Redelmeier M. P., Gournier H., Garcia-Pons F., Moussa M., Joliot A. H., Volovitch M. et al. (1996) Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo. J. Immunol. 157: 650-655
21. Pietersz G. A., Li W. and Apostolopoulos V. (2001) A 16-mer peptide (RQIKIWFQNRRMKWKK) from antennapedia preferentially targets the class I pathway. Vaccine 19: 1397-1405
22. Shibagaki N. and Udey M. C. (2002) Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity. J. Immunol. 168: 2393-2401
23. Shibagaki N. and Udey M. C. (2003) Dendritic cells transduced with TAT protein transduction domain-containing tyrosinase-related protein 2 vaccinate against murine melanoma. Eur. J. Immunol. 33: 850-860
24. Laus R., Graddis T. J., Hakim I. and Vidovic D. (2000) Enhanced major histocompatibility complex class I-dependent presentation of antigens modified with cationic and fusogenic peptides. Nat. Biotechnol. 18: 1269-1272
25. Wang R. F. and Wang H. Y. (2002) Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells. Nat. Biotechnol. 20: 149-154
26. Kim D. T., Mitchell D. J., Brockstedt D. G., Fong L., Nolan G. P., Fathman C. G. et al. (1997) Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide. J. Immunol. 159: 1666-1668
27. Schutze-Redelmeier M. P., Kong S., Bally M. B. and Dutz J. P. (2004) Antennapedia transduction sequence promotes anti tumour immunity to epicutaneously administered CTL epitopes. Vaccine 22: 1985-1991
28. Hogquist K. A., Jameson S. C., Heath W. R., Howard J. L., Sevan M. J. and Carbone F. R. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27
29. Moore M. W., Carbone F. R. and Bevan M. J. (1988) Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54: 777-785
30. Takahashi N., Orita T. and Hirose M. (1995) Production of chicken ovalbumin in Escherichia coli. Gene 161: 211-216
31. Dranoff G., Jaffee E., Lazenby A., Golumbek P., Levitsky H., Brose K. et al. (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90: 3539-3543